Comparison of pneumonitis risk between immunotherapy alone and in combination with chemotherapy: an observational, retrospective pharmacovigilance study

• Main Authors: Huixia Li (Author), Yifan Zheng (Author), Peihang Xu (Author), Zimu Li (Author), Yukun Kuang (Author), Xiaoqing Feng (Author), Junhao He (Author), Jia Li (Author), Xiao Chen (Author), Lihong Bai (Author), Ke-Jing Tang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Importance: Checkpoint inhibitor pneumonitis (CIP) is a rare but serious adverse event that may impact treatment decisions. However, there is limited information comparing CIP risks between immune checkpoint inhibitor (ICI) monotherapy and combination with chemotherapy due to a lack of direct cross-...